In Vitro Characterization of the Mechanisms Responsible for Functional Tricuspid Regurgitation
Erin M. Spinner(Boston Children's Hospital), Ajit P. Yoganathan(The Wallace H. Coulter Department of Biomedical Engineering), Emir Veledar(University of Miami), Patrick Shannon(Mount Sinai Hospital), David Adams(Mount Sinai Health System), Pedro J. del Nido(Boston Children's Hospital), Jorge H. Jimenez(Boston Children's Hospital), Dana Buice(Boston Children's Hospital)
Cited by 131
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden
|Circulation|2008|1.6k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
|New England Journal of Medicine|2013|961